Glucocorticoid-induced tumor necrosis factor receptor (TNFR) (GITR) family-related gene is a member of the TNFR super family. GITR works as one of the immunoregulatory molecule on CD4 1 regulatory T cells and has an important role on cell survival or cell death in CD4 1 T cells. Little is known about the expression of GITR on human CD8
Glucocorticoid-induced tumor necrosis factor receptor (TNFR) (GITR) family-related gene is a member of the TNFR super family. GITR works as one of the immunoregulatory molecule on CD4
1 regulatory T cells and has an important role on cell survival or cell death in CD4 1 T cells. Little is known about the expression of GITR on human CD8
1 T cells on antigen-specific and non-specific activation. Here, we report that expression of GITR on human CD8
1 T cells on T-cell receptor (TCR) (anti-CD3)-mediated stimulation is dependent on the JNK pathway. The activation of CD8 1 T cells was measured by the expression of IL-2 receptor-a (CD25), GITR and by IFN-g production upon re-stimulation with anti-CD3 antibody. We studied the signaling pathway of such inducible expression of GITR on CD8 1 T cells. We found that a known JNK-specific inhibitor, SP600125, significantly down-regulates GITR expression on anti-CD3 antibody-mediated activated CD8
1 T cells by limiting JNK phosphorylation. Subsequently, after stimulation of the CD8 1 cells, we tested for the production of IFN-g by the activated cells following restimulation with the same stimulus. It appears that the expression of GITR on activated human CD8 1 T cells might also be regulated through the JNK pathway when the activation is through TCR stimulation. Therefore, GITR serves as an activation marker on activated CD8
1 cells and interference with JNK phosphorylation, partially or completely, by varying the doses of SP600125
Introduction
Glucocorticoid-induced tumor necrosis factor (TNFR) (GITR) family-related gene, a member of the TNFR super family (TNFRSF), was originally cloned in a glucocorticoid-treated hybridoma T cell line. [1] [2] [3] Many reports are available about its expression on CD4 1 T cells
as an important component of the immunoregulatory unit. [3, 4] It has a high homology with other TNFRSF members.
are known to express higher levels of surface GITR, which may regulate the immunosuppressive function of CD4 1 T-reg. [2, 3] It is also reported that GITR regulate activation induced cell death (AICD) in murine T cells and exert costimulatory function. [6] Most of the work on GITR has been performed on CD4 
Materials and Methods

Reagents
Monoclonal antibodies: Anti-human GITR FITC mAb, anti-human CD8 PE mAb, purified phopspho-specific JNK mAb, goat anti-mouse APC mAb and purified anti-human CD3mAb were purchased from BD Biosciences (San Jose, CA, USA). Inhibitors for various kinase pathways, such as SB203580 (SB) for p38 kinase, SP600125 (SP)
for JNK and PD98059 (PD) for ERK were purchased from BIOMOL (Plymouth Meeting, PA, USA). Twentyfive micromolar concentration of the inhibitors, dissolved in DMSO, for various kinases, were used as described earlier. [7] Peripheral blood lymphocytes (PBL): Human PBL were isolated on a Ficoll-Hypaque gradient as described earlier. [8, 9] The participants were included in this study with informed consent.
Cells and culture media
Tissue culture technique and the procedure have been described earlier. [8] [9] [10] and L-glutamine (1.5 nM), (Life Technologies Inc.)
henceforth described as complete medium (CM).
Purification of CD8 1 T cells
Human CD8 1 T cells from PBL were isolated as described previously [8, 9] as per the manufacturer's The method for phenotypic analyses in flow cytometry has been described previously. [8, 9] Briefly, cell surface staining was carried out with fluorochrome-conjugated monoclonal antibodies for CD8, CD25 and GITR. Intracellular staining on CD8 1 T cells for JNK was performed using phopsphospecific JNK mAb, appropriate secondary conjugated antibody and Cytofix/Cytoperm reagent (BD Biosciences).
IFN-g enzyme-linked immunosorbent assay
Supernatant from CD8 1 T -cell culture (72 h) was kept in (2)708C until use. The supernatants were assayed for IFN-g in ELISA as per the manufacturer's (DuoSet ELISA Development System, RandD System) protocol, which is described earlier. [8, 9] Results First, we studied the expression of GITR on human CD8 1 T cells after stimulation with anti-CD3 antibody.
We performed flow cytometric analysis of GITR on CD8 showing that anti-CD3 stimulation up regulates CD25 on a majority of the T cell subset (data not shown). As JNK is known to regulate IL-2Ra (CD25) on activated T cells, [11] [12] [13] we were interested to see whether the expression of GITR ). Here, we found that both IFN-g production and JNK phosphorylation (JNK-
) were significantly down-regulated by SP600125
[ Figure 2 ].
Discussion
The c-Jun amino terminal kinase (JNK) signaling Recently, in the mouse model, it has been shown that GITR can costimulate along with TCR-driven stimulation in CD4 1 CD25 T cells for ERK activation. [6] But, the involvement of JNK in human CD8 1 T cells in relation to GITR expression is yet to be established. Here, we found the regulatory effect of JNK inhibitor (SP600125) [12] to down-regulate GITR on human CD8 1 T cells [ Figure 1 ].
During an immune response, the CD8 1 T cells take a leading role in infection immunity and exert several effector functions [12] [13] [14] [15] [16] and also become the regulatory target in tumor immunity and autoimmunity. [8, 15] 
